U.S DOJ resolves Balt SAS bribery case, forcing the company to disgorge $1.2 M after self-disclosure, while charging 2 executives with FCPA and ML violations for illicit payments to a French hospital doctor

DOJ finds that Balt paid bribes between 2017 and 2023 to a physician at a state-owned hospital in France to secure purchases of medical devices, with payments disguised as consulting fees and routed through intermediaries using sham contracts and false invoices. While the company avoids prosecution due to voluntary self-disclosure, cooperation and remediation, it agrees to approximately $1.2 million in disgorgement, and U.S. authorities indict a healthcare executive and consultant, underscoring continued enforcement against individuals involved in Foreign Corrupt Practices Act violations…